Published in J Mol Biol on September 10, 1999
Lovastatin: Immunomodulatory Value Evaluation (LIVE) | NCT00721305
Structural basis of integrin regulation and signaling. Annu Rev Immunol (2007) 8.60
Structures of the alpha L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell (2003) 4.19
Interpretation of ensembles created by multiple iterative rebuilding of macromolecular models. Acta Crystallogr D Biol Crystallogr (2007) 3.07
Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol (2011) 2.58
Integrins as therapeutic targets: lessons and opportunities. Nat Rev Drug Discov (2010) 2.27
NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding. Proc Natl Acad Sci U S A (2000) 1.75
An isolated, surface-expressed I domain of the integrin alphaLbeta2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide bond. Proc Natl Acad Sci U S A (2001) 1.68
Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water. J Biomol NMR (2000) 1.66
Intersubunit signal transmission in integrins by a receptor-like interaction with a pull spring. Proc Natl Acad Sci U S A (2004) 1.49
Regulation of integrin affinity on cell surfaces. EMBO J (2011) 1.47
The beta-tail domain (betaTD) regulates physiologic ligand binding to integrin CD11b/CD18. Blood (2006) 1.40
Activation of integrin beta-subunit I-like domains by one-turn C-terminal alpha-helix deletions. Proc Natl Acad Sci U S A (2004) 1.35
A general method for discovering inhibitors of protein-DNA interactions using photonic crystal biosensors. ACS Chem Biol (2008) 1.25
Dynamic shifts in LFA-1 affinity regulate neutrophil rolling, arrest, and transmigration on inflamed endothelium. Blood (2005) 1.22
Stabilizing the integrin alpha M inserted domain in alternative conformations with a range of engineered disulfide bonds. Proc Natl Acad Sci U S A (2002) 1.18
Efalizumab binding to the LFA-1 alphaL I domain blocks ICAM-1 binding via steric hindrance. Proc Natl Acad Sci U S A (2009) 1.13
Crystal structure of isoflurane bound to integrin LFA-1 supports a unified mechanism of volatile anesthetic action in the immune and central nervous systems. FASEB J (2009) 1.12
A small molecule agonist of an integrin, alphaLbeta2. J Biol Chem (2006) 1.04
Suppression of autoimmune retinal disease by lovastatin does not require Th2 cytokine induction. J Immunol (2005) 1.04
The volatile anesthetic isoflurane perturbs conformational activation of integrin LFA-1 by binding to the allosteric regulatory cavity. FASEB J (2008) 1.02
Insights into integrin-ligand binding and activation from the first crystal structure. Arthritis Res (2002) 0.99
LFA-1 affinity regulation is necessary for the activation and proliferation of naive T cells. J Biol Chem (2009) 0.97
Lymphocyte function antigen-1 mediates leukocyte adhesion and subsequent liver damage in endotoxemic mice. Br J Pharmacol (2004) 0.96
Isoflurane binds and stabilizes a closed conformation of the leukocyte function-associated antigen-1. FASEB J (2012) 0.94
Sevoflurane binds and allosterically blocks integrin lymphocyte function-associated antigen-1. Anesthesiology (2010) 0.93
A simple, no-wash cell adhesion-based high-throughput assay for the discovery of small-molecule regulators of the integrin CD11b/CD18. J Biomol Screen (2007) 0.92
NMR structure of a complex between MDM2 and a small molecule inhibitor. J Biomol NMR (2004) 0.91
An integrative in silico approach for discovering candidates for drug-targetable protein-protein interactions in interactome data. BMC Pharmacol (2007) 0.91
Statins in the critically ill. Ann Intensive Care (2012) 0.90
Competition between intercellular adhesion molecule-1 and a small-molecule antagonist for a common binding site on the alphal subunit of lymphocyte function-associated antigen-1. Protein Sci (2005) 0.89
Statins inhibit lymphocyte homing to peripheral lymph nodes. Immunology (2006) 0.88
Structural basis and kinetics of force-induced conformational changes of an αA domain-containing integrin. PLoS One (2011) 0.88
Statins, Bcl-2, and apoptosis: cell death or cell protection? Mol Neurobiol (2013) 0.87
Sedative drug modulates T-cell and lymphocyte function-associated antigen-1 function. Anesth Analg (2011) 0.86
A novel flow cytometric high throughput assay for a systematic study on molecular mechanisms underlying T cell receptor-mediated integrin activation. PLoS One (2009) 0.85
HMG CoA reductase inhibitors (statins) to treat Epstein-Barr virus-driven lymphoma. Br J Cancer (2005) 0.84
Inhibition of beta(2) integrin-mediated leukocyte cell adhesion by leucine-leucine-glycine motif-containing peptides. J Cell Biol (2001) 0.84
A statin-based inhibitor of lymphocyte function antigen-1 protects against ischemia/reperfusion-induced leukocyte adhesion in the colon. Br J Pharmacol (2003) 0.84
Antiretroviral effect of lovastatin on HIV-1-infected individuals without highly active antiretroviral therapy (The LIVE study): a phase-II randomized clinical trial. Trials (2009) 0.82
Controlling immune response and demyelination using highly potent bifunctional peptide inhibitors in the suppression of experimental autoimmune encephalomyelitis. Clin Exp Immunol (2013) 0.81
FRET based quantification and screening technology platform for the interactions of leukocyte function-associated antigen-1 (LFA-1) with intercellular adhesion molecule-1 (ICAM-1). PLoS One (2014) 0.80
NMR characterization of the conformational fluctuations of the human lymphocyte function-associated antigen-1 I-domain. Protein Sci (2014) 0.80
Propofol shares the binding site with isoflurane and sevoflurane on leukocyte function-associated antigen-1. Anesth Analg (2013) 0.80
Glatiramer acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system? Int J Mol Sci (2012) 0.78
High-throughput screening based identification of small molecule antagonists of integrin CD11b/CD18 ligand binding. Biochem Biophys Res Commun (2010) 0.78
Lovastatin Inhibits Low Molecular Weight Hyaluronan Induced Chemokine Expression via LFA-1 and Decreases Bleomycin-Induced Pulmonary Fibrosis. Int J Biomed Sci (2014) 0.76
Adhesion molecules in CNS disorders: biomarker and therapeutic targets. CNS Neurol Disord Drug Targets (2013) 0.75
Structural Basis for Simvastatin Competitive Antagonism of Complement Receptor 3. J Biol Chem (2016) 0.75
Identification and X-ray co-crystal structure of a small-molecule activator of LFA-1-ICAM-1 binding. Angew Chem Int Ed Engl (2014) 0.75
Effect of statins on lipoprotein receptor expression in cell lines from human mast cells and basophils. Eur J Clin Pharmacol (2003) 0.75
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med (2001) 3.69
SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo. Transplantation (1997) 2.80
An improved method for two-dimensional gel-electrophoresis: analysis of mutationally altered ribosomal proteins of Escherichia coli. Mol Gen Genet (1981) 1.83
Correct folding of circularly permuted variants of a beta alpha barrel enzyme in vivo. Science (1989) 1.76
A rapid method for evaluation of cell number and viability by flow cytometry. Cytotechnology (1997) 1.35
NMR solution structure of the pathogenesis-related protein P14a. J Mol Biol (1997) 1.30
NMR solution structure of the inserted domain of human leukocyte function associated antigen-1. J Mol Biol (2000) 1.27
Synthesis of ribosomal proteins in merodiploid strains and in minicells of Escherichia coli. Mol Gen Genet (1977) 1.09
SDZ RAD, a new rapamycin derivative: synergism with cyclosporine. Transplantation (1997) 1.06
Phosphorylation of eIF-4E on Ser 209 in response to mitogenic and inflammatory stimuli is faithfully detected by specific antibodies. Mol Cell Biol Res Commun (2000) 1.02
Chemical modification of rapamycin: the discovery of SDZ RAD. Transplant Proc (1998) 1.01
Increased mature interleukin-1beta (IL-1beta) secretion from THP-1 cells induced by nigericin is a result of activation of p45 IL-1beta-converting enzyme processing. J Biol Chem (1998) 1.01
FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects. Transplant Proc (2001) 0.95
Cell-free biosynthesis of new cyclosporins. J Antibiot (Tokyo) (1989) 0.95
A homogeneous fluorometric assay for measuring cell adhesion to immobilized ligand using V-well microtiter plates. Anal Biochem (2001) 0.93
Validation of new aromatase monoclonal antibodies for immunohistochemistry: progress report. J Steroid Biochem Mol Biol (2003) 0.93
The discovery of steroids and other novel FKBP inhibitors using a molecular docking program. J Mol Biol (1999) 0.92
Cold-sensitive growth of a mutant of Escherichia coli with an altered ribosomal protein S8: analysis of revertants. Mol Gen Genet (1977) 0.92
Localized mutagenesis of the aroE-strA section of the Escherichia coli chromosome coding for ribosomal proteins. Mol Gen Genet (1975) 0.91
Indoleglycerol phosphate synthase-phosphoribosyl anthranilate isomerase: comparison of the bifunctional enzyme from Escherichia coli with engineered monofunctional domains. Biochemistry (1995) 0.88
Effects of soluble interleukin-1 type II receptor on rabbit antigen-induced arthritis: clinical, biochemical and histological assessment. Rheumatology (Oxford) (1999) 0.86
A novel approach for high level production of a recombinant human parathyroid hormone fragment in Escherichia coli. Biotechnology (N Y) (1994) 0.84
Crystal structure of the SH2 domain from the adaptor protein SHC: a model for peptide binding based on X-ray and NMR data. J Mol Biol (1995) 0.84
Heteronuclear X-filter 1H PFG double-quantum experiments for the proton resonance assignment of a ligand bound to a protein. J Magn Reson (1998) 0.83
Functional serotonin 5-HT1D receptors and 5-HT1D beta receptor mRNA expression in human umbilical vein endothelial cells. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.82
Species-specific and conserved epitopes on mouse and human E-selectin important for leukocyte adhesion. Exp Cell Res (2001) 0.82
In vitro biosynthesis of [Thr2, Leu5, D-Hiv8, Leu10]cyclosporin, a cyclosporin-related immunosuppressive peptolide. Biomed Biochim Acta (1991) 0.81
Assignment of 1H, 13C and 15N resonances of the I-domain of human leukocyte function associated antigen-1. J Biomol NMR (2000) 0.80
The occurrence of low alpha-L-fucosidase activities in normal human serum. Biochim Biophys Acta (1975) 0.80
Half-filter experiments for assignment, structure determination and hydration analysis of unlabelled ligands bound to 13C/15N labelled proteins. J Biomol NMR (1999) 0.80
Synthesis of novel 6-amido-6-deoxy-l-galactose derivatives as sialyl Lewis X mimetics. Bioorg Med Chem (1997) 0.79
In vitro biosynthesis of [Thr2,Leu5,D-Hiv8,Leu10]-cyclosporin, a cyclosporin-related peptolide, with immunosuppressive activity by a multienzyme polypeptide. J Biol Chem (1991) 0.79
New pulsed field gradient NMR experiments for the detection of bound water in proteins. J Biomol NMR (1995) 0.79
Cleavage of the cyclohexyl-subunit of rapamycin results in loss of immunosuppressive activity. Bioorg Med Chem Lett (1999) 0.78
Interactions between a symmetrical minor groove binding compound and DNA oligonucleotides: 1H and 19F NMR studies. J Biomol Struct Dyn (1989) 0.78
[Detection of an early activation-dependent cell surface antigen on human T-lymphocytes]. Allerg Immunol (Leipz) (1989) 0.75
Synthesis of sialyl Lewis x mimetics as selectin inhibitors by enzymatic aldol condensation reactions. Bioorg Med Chem (1999) 0.75
Proton microprobe development. Science (1990) 0.75
Examination of the photokinetics of 1-beta-D-arabinofuranosylcytosine and deoxyribocytidine. Photochem Photobiol (1988) 0.75
Synthesis of sialyl Lewis X mimetics using the Ugi four-component reaction. Bioorg Med Chem Lett (1998) 0.75
Design and synthesis of C-linked fucosides as inhibitors of E-selectin. Bioorg Med Chem (1996) 0.75
Assembly of binding loops on aromatic templates as VCAM-1 mimetics. J Pept Sci (1999) 0.75
A simple method for the crystallization of beef liver crotonase. Biochim Biophys Acta (1974) 0.75
[The validity of parameters in neonatal diagnosis and fetal monitoring of breech deliveries. 2. Problems in fetal monitoring in the breech position--a proposal for a standardized biochemical diagnosis]. Zentralbl Gynakol (1989) 0.75
Comparative structural studies of urinary glycosaminoglycans in the Hurler and Hunter syndromes. Biochim Biophys Acta (1975) 0.75
Design, synthesis and biological evaluation of aryl-substituted sialyl Lewis X mimetics prepared via cross-metathesis of C-fucopeptides. Bioorg Med Chem (1999) 0.75